Actively Recruiting

Phase 4
Age: 18Years - 70Years
All Genders
NCT05408247

A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder

Led by University of Sydney · Updated on 2023-03-16

280

Participants Needed

3

Research Sites

193 weeks

Total Duration

On this page

Sponsors

U

University of Sydney

Lead Sponsor

M

Monash University

Collaborating Sponsor

AI-Summary

What this Trial Is About

To explore the effectiveness of n-acetylcysteine in improving treatment outcomes for alcohol use disorder in a double-blind randomised placebo-controlled trial.

CONDITIONS

Official Title

A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Alcohol Use Disorder according to the DSM-V criteria
  • Desire to reduce or stop drinking
  • Consumed at least 21 standard drinks per week or 2 heavy drinking days per week in the month prior to screening
  • Adequate cognition and English skills to give valid consent and complete interviews
  • Stable housing
  • Willingness to provide written informed consent
Not Eligible

You will not qualify if you...

  • Pregnancy or lactation (women must use reliable contraception during the trial)
  • Use of psychotropic medications other than stable-dose antidepressants
  • Dependence on substances other than nicotine
  • Clinically unstable medical or psychiatric disorders that prevent participation
  • Concurrent use of selenium, vitamin D, or other antioxidants
  • Use of any alcohol pharmacotherapy within the past month

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Drug Health Services, Royal Prince Alfred Hospital

Sydney, New South Wales, Australia, 2050

Actively Recruiting

2

Cornwall Street Medical Centre (UQ Health Care)

Annerley, Queensland, Australia, 4103

Not Yet Recruiting

3

Turning Point

Richmond, Victoria, Australia, 3121

Active, Not Recruiting

Loading map...

Research Team

K

Kirsten Morley, PhD

CONTACT

P

Paul Haber, MBBS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here